GlassScriptPhysician profile
Robbie L Hurtt
NPI 1386908762
$4,019.93
in general payments reported to CMS, 2019-2025
31 companies · $788 in 2025
The $788 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $447 · 2021: $386 · 2022: $465 · 2023: $477 · 2024: $953 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.05 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $601.00 | 2019-2025 | General - Erectile Dysfunction, Lumenis Pulse 120h, Rezum Generator |
| Sumitomo Pharma America, INC. | $503.02 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $316.28 | 2020-2024 | Myrbetriq, Xtandi |
| Abbvie INC. | $296.78 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $238.02 | 2019-2025 | |
| Pfizer INC. | $201.36 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $200.81 | 2019-2025 | Provenge |
| Verity Pharmaceuticals INC. | $187.09 | 2023-2025 | Trelstar |
| Coloplast Corp | $164.29 | 2024-2025 | |
| Amgen INC. | $156.08 | 2019-2021 | |
| Myovant Sciences INC. | $145.64 | 2022 | |
| Myriad Genetic Laboratories, INC. | $103.42 | 2020-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $95.46 | 2020-2025 | Keytruda, Lynparza |
| Blue Earth Diagnostics | $95.07 | 2019-2024 | |
| Procept Biorobotics Corporation | $91.45 | 2020-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $88.75 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Teleflex LLC | $68.83 | 2021-2024 | Urolift |
| Axonics, INC. | $62.51 | 2020-2023 | Axonics |
| Allergan, INC. | $54.67 | 2019-2021 | |
| Janssen Biotech, INC. | $50.21 | 2019-2020 | |
| Medtronic USA, INC. | $50.08 | 2019-2020 | |
| Tolmar, INC. | $48.78 | 2024-2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $48.66 | 2021-2023 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $28.10 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $23.99 | 2022 | |
| Antares Pharma, INC. | $20.71 | 2023 | Nocdurna, Tlando, Xyosted |
| Genzyme Corporation | $19.81 | 2023 | |
| Caris Mpi, INC. | $18.74 | 2025 | Mi Cancer Seek |
| Photocure INC | $17.53 | 2022 | |
| Foundation Medicine, INC. | $11.50 | 2020 | |
| Medtronic, INC. | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robbie Hurtt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.